top of page
ICERB-2018
Satellite Symposium
Satellite Symposium will be held on 29th and 30th October in Department of Biotechnology smart class room. Satellite symposium will encourage participation of foreign delegates and the delegates physically attending the conference will be benefited by these presentations.
Dr. F. Scott Hall
Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, Ohio, USA
President, International Behavioral Neuroscience society
http://www.ibnsconnect.org
Dr. Ravi K Kamepalli
Bariatric Medicine, Infectious Diseases
Mercy Health, Lima, OH, USA
Dr. Pradeep Shukla
Faculty in Neuroscience @University of Tennessee Health Science center
Memphis, TN, USA
Dr. Anil Shakar
Faculty in Biochemistry and Cancer Biology
@ Meharry Medical College
Nashville, TN, USA
Dr. Paras Mishra
Faculty in MicroRNomics of cardiovascular diseases and diabetic cardiomyopathy
@ University of Nebraska Medical Center
Omaha, Nebraska, USA
Dr. Umesh Jinwal
Faculty in Department of Pharmaceutical Sciences @ USF College of Pharmacy
Tampa, FL, USA
Dr. Alexander Marson
University of California, San Francisco
San Francisco, CA, USA
Scientist, Physician and Innovator. One of the leading figures in propagating the revolutionary CRISPR technology.
Dr. Dinesh Verma
Dr. Verma research involves understanding the pathogenesis of tumor viruses, specifically Epstein Barr Virus (EBV) and Kaposi’s sarcoma associated herpesvirus (KSHV). Both viruses undergo lytic replication in epithelial cells during primary infection and during reactivation from latent infection in B-lymphocytes.
College of Medicine, University of Utah, San Francisco
San Francisco, CA, USA
Dr. Subhash C. Verma
Associate Professor
Department of Microbiology and Immunology
University of Nevada, Reno, Nevada, USA
Dr. Verma is interested in understanding the mechanism of KSHV genome replication during reactivation as well as during de-novo infection of human cells. Kaposi's sarcoma associated herpesvirus (KSHV), also referred, as Human Herpesvirus 8 (HHV8) is tightly linked to various human malignancies including Primary Effusion Lymphomas (PELs), Kaposi's sarcoma (KS) and Multicentric Castleman's Disease (MCDs) and cause tumors predominantly in immune compromised individuals including HIV+ and patients receiving immune suppressive therapies to prevent graft rejection
bottom of page